You just read:

GlaxoSmithKline's (GSK) $3 Billion Whistleblower Settlement Has Paid for One Of America's Most Expensive Failed Corporate Internal Investigations, Qui Tam Whistleblowers' Attorneys Say

News provided by

Kenney & McCafferty, P.C.

Jul 02, 2012, 11:48 ET